Digital Health Investors & VC Firms in Europe

510 firms in this list, with a median first check of $540K. 156 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
V3 V3 Ventures AVLCAAB11 people	88🔒	London	GB	Pre-Seed–Growth	$1M – $5M	+ Add to CRM
HE Heal Capital CLDMEWDC16 people · Leads rounds	88🔒	Berlin	DE	Pre-Seed–Late Stage	$1.1M – $5.4M	+ Add to CRM
AP Apposite Capital DPNHDBJH22 people · Leads rounds	88🔒	London	GB	Growth–Late Stage	—	+ Add to CRM
AS Asabys Partners CCJLGMJM18 people · Follows rounds	88🔒	Barcelona	ES	Seed–Growth	—	+ Add to CRM
ST Start Codon AWAHIJIL24 people	88🔒	Cambridge	GB	Pre-Seed–Seed	—	+ Add to CRM
TE Teampact.ventures BABKRVLS20 people	88🔒	—	FR	—	—	+ Add to CRM
KI Kinnevik TSAACSAH10 people	88🔒	Stockholm	SE	Seed–Late Stage	—	+ Add to CRM
AC Act Venture Capital DRJFJOAO12 people · Leads rounds	88🔒	Dublin	IE	Seed–Late Stage	—	+ Add to CRM
HA Hadean Ventures ITRFWSGA21 people	88🔒	Oslo	NO	Seed–Growth	—	+ Add to CRM
HO HOWZAT Partners DSDTSH3 people	88🔒	Luxembourg	LU	Pre-Seed–Series A	—	+ Add to CRM
QB Qbic Fund CVMDSBSL18 people · Follows rounds	88🔒	St-Denijs-Westrem	BE	Pre-Seed–Series A	—	+ Add to CRM
O2 O2h Ventures PSSSAMCR23 people	88🔒	Cambridge	GB	Pre-Seed–Series A	—	+ Add to CRM
SP Spex Capital DCDTBSCD23 people	88🔒	London	GB	Pre-Seed–Series B	$500K – $5M	+ Add to CRM
RH Rheingau Founders DTPHJRNM9 people · Leads rounds	88🔒	Berlin	DE	Pre-Seed–Late Stage	$220K – $1.6M	+ Add to CRM
DE Debiopharm Innovation Fund TMCTDSMC18 people · Leads rounds	88🔒	Lausanne	CH	Pre-Seed–Late Stage	$1M – $5M	+ Add to CRM
HB HBM Healthcare Investments AWCPDEDR8 people	88🔒	Zug	CH	Growth–Late Stage	—	+ Add to CRM
RO Rockaway Ventures ALDZKHPŠ16 people · Leads rounds	88🔒	Praha 6 – Dejvice	CZ	Seed–Late Stage	—	+ Add to CRM
VE Ventech AONFSWTB7 people	88🔒	Paris	FR	Seed–Growth	$540K – $5.4M	+ Add to CRM
EX Exceptional Ventures MCPPFRSC16 people · Follows rounds	88🔒	London	GB	Pre-Seed–Series A	—	+ Add to CRM
NO Nordic Capital KMCHHJJS13 people · Leads rounds	88🔒	Stockholm	SE	Growth–Late Stage	—	+ Add to CRM
MO Montagu HWCCDFGJ19 people	88🔒	London	GB	—	—	+ Add to CRM
PL Planven Entrepreneur Ventures GCRBACEW19 people · Leads rounds	88🔒	Zurich	CH	Seed–Late Stage	$10M – $20M	+ Add to CRM
CR Crowberry Capital HAHVJRSH11 people	88🔒	Reykjavík	IS	Pre-Seed–Series A	$220K – $2.2M	+ Add to CRM
LA Lauxera Capital Partners ASPMSLEF18 people · Leads rounds	88🔒	Paris	FR	Growth–Late Stage	$22M – $110M	+ Add to CRM

V3 Ventures

LondonPre-Seed–Growth$1M – $5M

AVLCAAB11 people

Heal Capital

BerlinPre-Seed–Late Stage$1.1M – $5.4M

CLDMEWDC16 people

Apposite Capital

LondonGrowth–Late Stage

DPNHDBJH22 people

Asabys Partners

BarcelonaSeed–Growth

CCJLGMJM18 people

Start Codon

CambridgePre-Seed–Seed

AWAHIJIL24 people

Teampact.ventures

BABKRVLS20 people

Kinnevik

StockholmSeed–Late Stage

TSAACSAH10 people

Act Venture Capital

DublinSeed–Late Stage

DRJFJOAO12 people

Hadean Ventures

OsloSeed–Growth

ITRFWSGA21 people

HOWZAT Partners

LuxembourgPre-Seed–Series A

DSDTSH3 people

Qbic Fund

St-Denijs-WestremPre-Seed–Series A

CVMDSBSL18 people

O2h Ventures

CambridgePre-Seed–Series A

PSSSAMCR23 people

Spex Capital

LondonPre-Seed–Series B$500K – $5M

DCDTBSCD23 people

Rheingau Founders

BerlinPre-Seed–Late Stage$220K – $1.6M

DTPHJRNM9 people

Debiopharm Innovation Fund

LausannePre-Seed–Late Stage$1M – $5M

TMCTDSMC18 people

HBM Healthcare Investments

ZugGrowth–Late Stage

AWCPDEDR8 people

Rockaway Ventures

Praha 6 – DejviceSeed–Late Stage

ALDZKHPŠ16 people

Ventech

ParisSeed–Growth$540K – $5.4M

AONFSWTB7 people

Exceptional Ventures

LondonPre-Seed–Series A

MCPPFRSC16 people

Nordic Capital

StockholmGrowth–Late Stage

KMCHHJJS13 people

Montagu

London

HWCCDFGJ19 people

Planven Entrepreneur Ventures

ZurichSeed–Late Stage$10M – $20M

GCRBACEW19 people

Crowberry Capital

ReykjavíkPre-Seed–Series A$220K – $2.2M

HAHVJRSH11 people

Lauxera Capital Partners

ParisGrowth–Late Stage$22M – $110M

ASPMSLEF18 people

Data sourced from public filings and firms' own websites — see our methodology.